Human HO1(Heme Oxygenase 1) ELISA Kit
中文名称:人血红素氧合酶1(HO1)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 0.31-20 ng/mL
- 灵敏度: 0.19 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人HO1抗体包被于酶标板上,实验时样品(或标准品)中的人HO1会与包被抗体结合。后依次加入生物素化的抗人HO1抗体和辣根过氧化物酶标记的亲和素,抗人HO1抗体与结合在包被抗体上的人HO1结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,HO1浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中HO1的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 0.31-20 ng/mL |
灵敏度 | 0.19 ng/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人HO1,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
IF: 9.300 -
Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells
IF: 4.900 -
Relationship between Brain Tissue Changes and Blood Biomarkers of Cyclophilin A, Heme Oxygenase-1, and Inositol-Requiring Enzyme 1 in Patients with Alzheimer’s Disease
IF: 3.706 -
Heme oxygenase-1 in osteosarcoma
IF: 1.326Journal: Journal of Cancer Research and Therapeutics (2020)PMID:32930133Reactivity:HumanSample Type:serum -
Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo
IF: 4.300Journal: International Journal of Nanomedicine (2017)PMID:28652743Reactivity:HumanSample Type:Cell culture supernatant,Serum -
KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells
IF: 1.390 -
Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1
IF: 3.611